• EROGMED - effective patient recruitment
  • Our Areas of Expertise
  • Site Management
  • Site Assessment
  • Site Efficiency
  • Rescue Strategies
• ERGOMED'S full service provision
  • Consultancy
  • Phase I/II a Unit
  • Central Laboratory
  • Project Management
  • Monitoring
  • Pharmacovigilance
  • Regulatory Affairs
  • Data Management & Biostatistics
  • Quality Assurance
• EROGMED partners with Biotech Venture Capital
  • Co-development strategies
  • Co-development financing
  • Co-development deals
• Company
  • Overview
  • Keys to Success
  • Management
    • Miroslav Reljanovic
    • Klemens Schuette
    • Scott Ferguson
  • Jobs
  • News
  • Events
• Contact
  • Locations
  • Contact us
  • Legal Information
•  

Co-Development Strategies.

In order to match the needs of biotech most effectively, ERGOMED offers very flexible co-development strategy models. ERGOMED has access to fundraising capabilities as well as being able to offer partnering strategies for co-development with companies.

Through its relationships with several private and public funding bodies with an interest in investment in the biotech sector, ERGOMED can enter into co-development partnership with clients where there is a mutual interest and expertise. This partnership could include services in clinical development, consultancy, risk-sharing strategies or financial support for client companies.

ERGOMED’s co-development program comprises of:
• Individual co-development strategy for a clinical product
• Access to fundraising capabilities
• co-development participation
• licensing strategies